Coagulopathy of COVID-19 and antiphospholipid antibodies
- PMID: 32379918
- PMCID: PMC7267637
- DOI: 10.1111/jth.14893
Coagulopathy of COVID-19 and antiphospholipid antibodies
Conflict of interest statement
NT Connell: no conflicts of interest. EM Battinelli: no conflicts of interest. JM Connors: research funding to her institution from CSL Behring and fees from Bristol‐Myers Squibb–Pfizer for serving on scientific advisory boards.
References
-
- Vila P, Hernandez MC, Lopez‐Fernandez MF, Batlle J. Prevalence, follow‐up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost. 1994;72:209‐213. - PubMed
-
- Bertolaccini ML, Amengual O, Andreoli L, et al. 14th International congress on antiphospholipid antibodies task force. Report on antiphospholipid syndrome laboratory diagnostics and trends. Autoimmun Rev. 2014;13:917‐930. - PubMed
Publication types
LinkOut - more resources
Full Text Sources